$DIGX Rolling Brief - Updated Mar 18, 2018. Extracts From

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
255
$DIGX Rolling Brief - Updated Mar 18, 2018. Extracts From Official Filings & PRs + Analysis From Observations.

Company portfolio comprises:

"Expressions Chiropractic & Rehab, PA" and "Expressions Property Limited, LP" - wholly owned subsidiaries located in Dallas and Cedar Hill, TX - currently operates two chiropractic and rehab centers in the Dallas-Fort Worth Metroplex area.

Management has developed a business plan which includes growth through the acquisition of existing chiropractic and rehabilitation centers in the Dallas-Fort Worth Metroplex area.

Management believes that they will be able to obtain the capital necessary to acquire multiple chiropractic and rehabilitation centers in the Dallas-Fort Worth Metroplex area - in effect “Branding” the "Expressions" name and specific operational characteristics of the company.

"Split Endings" - a wholly owned subsidiary - is an upscale beauty salon located in Cedar Hill, TX.

Management has developed a business plan which includes growth through the acquisition of privately owned salons and spas in the Dallas-Fort Worth Metroplex area.

Management believes that they will be able to obtain the capital necessary to acquire multiple privately owned salons and spas in the Dallas-Fort Worth Metroplex area - in effect “Branding” the "Split Endings" name and specific operational characteristics of the company.

The Company is also actively seeking out suitable mergers, acquisitions and/or joint ventures , which would enhance our company's value.

Company websites:

http://www.expressionschiropractic.com/

http://www.splitendings.com/welcome.html

$DIGX Share Structure - TA Verified Company Profile - Updates As At Feb 28, 2018:

Authorized Shares: 2,100,000,000 - as at Feb 28, 2018 [no change]

Outstanding Shares: 1,830,612,000 - as at Feb 28, 2018 [reduced by 30,000,000 since January 30, 2017]

Restricted: 208,800,000 - as at Feb 28, 2018 [no change].

Unrestricted: 1,621,812,000 - as at Feb 28, 2018 [no change].

Held at DTC: 1,440,941,334 - as at Feb 28, 2018 [425M retired since May 31, 2017 - 150M retired May 31 > Jul 31 - 275M retired Jul 31 > Oct 31 - total 425M = very good - not available to individual investors].

Float: 1,621,812,000 - as at Sep 30, 2017 [reduced by 50,000,000 since December 31, 2016].

There has been no dilution in 2017 or in 2018.

The share structure has headroom between the A/S and the O/S and is not maxed out.

The O/S was actually reduced in 2017 - thereby increasing the headroom between the A/S and the O/S.

The 2017 Annual Report confirmed that no shares were issued for convertible debt in Q4. Only 15M total were issued in the whole of 2017.

The Attorney Opinion Letter for the 2017 Annual Report was filed and accepted on Mar 9, 2018

There is absolutely no need to even consider a reverse split (as experienced traders who specialize in stocks under .01 well know).

$DIGX was the highest banked profit stock for those that traded it correctly in 2017 due to its proven history of regular repeat runs on the excellent financial results each quarter.

A contemporaneous record of trading for every day in 2017 and to date in 2018 has been maintained here on Investors Hangout.

From my observations, a number of the most successful traders in the OTC have been creating an inventory of shares at the year bottom prices in Q4 2017, and so far in 2018, not only to trade on surges but also to deny as many shares as possible to low level flippers and to those that use disinformation and a stacked ask in attempts to get cheap shares.

263M shares have been bought at .0003 since Sep 15, 2017 - almost all by savvy traders who intentionally bid for them.

566M shares have been bought at .0004 since Aug 23, 2017 - almost all by traders who bought on the ask. Of these 131M have been in 2018 [including 51M bought in a few minutes on the ask on Jan 11].

6M shares have been bought at .0005 since Jan 19, 2018 - all by traders who bought on the ask.

The 2017 Annual Report was filed 25 days early on March 6, 2018.

Proven, excellent financial results which set off several runs in 2017:

2017 Gross Revenue: $1,980,130.

2017 Gross Profit: $1,932,177.

2017 Net Profit: $234,138 [rare in the OTC].

As expected, Q4 revenue was up compared to the average of Q1>Q3.

All net profits are held as cash at the bank and therefore available for planned brand expansion and acquisitions [rare in the OTC].

The company is rated as a "Going Concern" [rare in the OTC].

Overall, $DIGX has generally filed quarterly reports in a timely manner in the modern era (since the acquisition of Expressions Chiropractic & Rehab in January 2016).

The filing of the 2017 Annual Report on Mar 6, 2018 - 25 days earlier than the 2016 Annual Report on Mar 31, 2017 - is noteworthy. The Attorney Opinion Letter followed in short order on Mar 9, 2018.

$DIGX is OTC Current and likely to remain so indefinitely..

There has never been any awareness campaign on $DIGX in the modern era - it is successful enough on its' filed financial performance to attract enthusiastic, high-volume, successful traders with a proven track record who have significant followings.

The Annual Report confirms that no shares have been issued in consideration of promotional campaigns.

Based on the 2017 cycle, we can expect to see:

A PR to the wider investment community highlighting the excellent results in the recently filed 2017 Annual Report. At present, it is mostly only current long-term investors specifically looking for the Annual Report who have seen it.

The 2018 Q1 results and a PR either before, after or both [filed on May 16, 2017 last year].

Further PR content outlining progress with implementation of the Strategic Growth Plan.

The first step was due to be increasing the range of services offered in all offices of the Expressions Chiropractic & Rehab chain thereby increasing the profitability of each location. That action has already yielded results with the anticipated increased profitability being delivered successfully in 2017 Q4.

The acquisition of additional already profitable locations that wanted to go public was also planned as part of the brand expansion.

More savvy, OTC market off-the-bottom specialist traders - who typically buy up to 150M > 300M at the first 2 to 3 available ask price points - out of the blue with no warning in seconds / minutes to ultimately get at least 100% > 150% per run - are likely to turn their attention to $DIGX again in the not so distant future due to its' repeat run performance. This has happened on at least one stock every week in 2018 so far - including coincidentally 2 of my long-term picks. Timing will - as always - depend on the dynamics of their other trades.

















American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 60

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 68

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 272

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 354

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 414

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 646

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 22

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 586

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Spring Health Launches Initiative for Mental Health Relief

Updated Category News Views 472

Spring Health's Commitment to Mental Health Support In response to the recent devastation from the wildfires, Spring Health has announced a significant initiative aimed at providing mental health resources to those in distress. The company has committed $500,000 to launch a new Wildfire Mental Health Support Program aimed at individuals and families impacted by these...

Continue Reading
Serina Therapeutics Showcases Innovations at Global Conference

Updated Category News Views 263

Serina Therapeutics Takes the Stage at Major Investment Event Serina Therapeutics, Inc., also known as Serina (NYSE American: SER), is set to make an impactful presentation at the H.C. Wainwright 27th Annual Global Investment Conference. This prestigious event unfolds in New York City, where Steve Ledger, the Chief Executive Officer of Serina, will take the spotlight at...

Continue Reading
Patrick Industries Faces Scrutiny Amid Merger Plans

Updated Category News Views 48

Cracks in the Merger Deal? Nobody likes it when a seemingly routine merger suddenly faces the magnifying glass of a class action attorney. But that's where we are with Patrick Industries (NASDAQ: PATK), folks. Juan Monteverde, the big hitter from Monteverde & Associates, is eyeing this one closely. This New York-based firm, perched in the legendary Empire State Building...

Continue Reading
Revolutionary Arab Human Pangenome: Advancing Genomic Equity

Updated Category News Views 124

Groundbreaking Achievement in Genomics PacBio, a renowned leader in sequencing technology, has made a substantial contribution to global genomics with the announcement of the first Arab human pangenome. This historic achievement is powered by their innovative HiFi long-read sequencing technology, showcasing the potential of genomic science to progress health equality...

Continue Reading
RCI Hospitality Secures Significant Legal Representation Ahead of Deadline

Updated Category News Views 226

Introduction to RCI Hospitality Holdings, Inc. RCI Hospitality Holdings, Inc. (NASDAQ: RICK) is known for its diverse portfolio in the hospitality sector. With establishments across the country, RCI focuses on providing entertainment and dining experiences through various brands. As an investor in RCI Hospitality, it’s essential to stay informed about recent legal...

Continue Reading